According to data that experts hailed as a potential breakthrough in how the virus is controlled, an experimental antiviral tablet produced by Merck & Co (MRK.N) might half the risks of dying or being hospitalized for individuals most at risk for getting severe COVID-19.
If approved by the US, molnupiravir, which is meant to induce mistakes into the virus’s genetic coding, would be the first oral antiviral treatment for COVID-19.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

PIA’s Kabul Operation Suspended

PIA’s Kabul Operation was suspended due to security uncertainty at Kabul Airport.…

Brazil to resume diplomatic relations with Venezuela

According to the reports, Brazil is set to restart diplomatic relations with…

World’s largest Star Sapphire Cluster discovered

Authorities of Sri Lanka reported that the world’s largest Star Sapphire Cluster…

Ukrainian drone crashes near Zaporizhzhia nuclear plant

A Ukrainian drone has crashed near the Zaporizhzhia nuclear power plant, Russia’s…